1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
No economic benefit of early knee reconstruction over optional delayed reconstruction for ACL tears: registry enriched randomised controlled trial data.
(
- Contribution to journal › Article
- 2014
-
Mark
Cost-Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden.
2014) In Diabetes therapy : research, treatment and education of diabetes and related disorders 5(2). p.591-607(
- Contribution to journal › Article
-
Mark
Health utilities of type 2 diabetes-related complications: a cross-sectional study in sweden.
(
- Contribution to journal › Article
- 2013
-
Mark
Towards renewed health economic simulation of type 2 diabetes: risk equations for first and second cardiovascular events from Swedish register data.
(
- Contribution to journal › Article
-
Mark
Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register.
(
- Contribution to journal › Article